Stay updated on Durvalumab & Tremelimumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab & Tremelimumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab & Tremelimumab in NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This is a minor technical update with no changes to study content or functionality.
    Difference
    0.0%
    Check dated 2026-03-12T20:23:46.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and Revision: v3.4.1 was removed. This is a minor version/metadata update that does not affect the study content or the page’s primary functions.
    Difference
    0.0%
    Check dated 2026-02-12T01:54:39.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.1 and removed Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-04T23:48:26.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page now includes a glossary toggle and a visible QC status field ('Last Update Submitted that Met QC Criteria'). The previous QC wording was removed/adjusted and versioning text was updated.
    Difference
    0.1%
    Check dated 2026-01-28T20:28:29.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Page revision label updated to Revision: v3.3.4, replacing v3.3.3, as a minor UI/version change. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T03:56:04.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Updated the study page by expanding the Locations section with additional site entries (Arizona, California, Colorado, Florida, Georgia, Illinois, Iowa, Kentucky, Maryland, Michigan, Missouri, Nebraska, New York, North Carolina, Ohio, Tennessee, Utah, Washington, and New Brunswick) and updating the revision to v3.3.3.
    Difference
    0.7%
    Check dated 2025-12-23T20:56:34.000Z thumbnail image

Stay in the know with updates to Durvalumab & Tremelimumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab & Tremelimumab in NSCLC Clinical Trial page.